Skip to content
Medical Health Aged Care, Science

World-first tag sheds new light on ‘disordered’ proteins in Parkinson’s

La Trobe University 3 mins read

Scientists at La Trobe University have created a world-first method to investigate ‘disordered’ proteins in living cells, in breakthrough research that could revolutionise how we understand and treat Parkinson’s disease.

 

Published in Nature Methods, the research used a cutting-edge chemical tag called TME, which binds with the proteins and makes them light up, allowing scientists for the first time to detect and capture them for analysis while in their unstructured or ‘disordered’ state.

 

The research also showed that using TME with existing investigative methods offers critical new insights into Parkinson’s disease by revealing how the proteins behave in living blood cells – a breakthrough which could help scientists better understand the causes of the disease.

 

Lead researcher Associate Professor Yuning Hong said the new chemical tool marked a significant advance in biological and biomedical research, and a crucial step towards the development of better treatments and eventually a cure for Parkinson’s disease.

 

“In nearly 85 per cent of cases of Parkinson’s disease the causes are unknown, but we do know that abnormal clumps or ‘aggregates’ of these proteins are a marker of the disease in its advanced stages,” Associate Professor Hong said.

 

“Not much is known about these proteins as previously they couldn’t be identified in live cells using traditional methods. With our TME chemical tag, researchers can now analyse the proteins’ behaviour directly in living cells – critical information for Parkinson’s disease and other neurodegenerative diseases.”

 

Disordered proteins differ from other protein types as they are not neatly folded to have a three-dimensional structure, giving them a unique flexibility which is key to their function and how they interact with other molecules.

 

However, abnormal behaviour in these proteins can lead to neurodegenerative disorders, including Parkinson’s disease, dementia and Huntington’s disease.

 

La Trobe University researcher Shouxiang Zhang, the paper’s first author, said current methods to analyse disordered proteins’ behaviour required scientists to first kill the cells they were housed in - a process which could change the proteins’ natural state.

 

“Disordered proteins are highly dynamic and heterogenous – their structure changes shape depending on their environment and killing the cell could alter their behaviour,” Shouxiang Zhang said.

 

By using TME to chemically tag disordered proteins, scientists can for the first time track their behaviour directly inside living cells.

 

When used in combination with other existing workflows, the tag helps scientists capture and concentrate the proteins for analysis on a large scale, giving crucial insight into how they change over time under different conditions.

 

For this study, the research team used TME to identify disordered proteins in Parkinson’s disease and Huntington’s disease.

 

They found it was better than traditional methods in differentiating the blood cells of Parkinson’s disease patients from healthy individuals. For Huntington’s disease, it revealed the mechanism of how affected cells trap disordered proteins in clusters.

 

Associate Professor Hong said understanding this mechanism was crucial information which opened new avenues of research to investigate the causes not only of Huntington’s, but also Parkinson’s.

 

“What leads to the proteins forming aggregates in the first place? Is it protective or is it detrimental to the cells? Using TME, we hope that researchers can answer these questions and design new treatments based on what they learn by observing the proteins’ behaviour in live cells over time,” Associate Professor Hong said.

 

In the future, Associate Professor Hong hopes to create similar tests to help scientists investigate other diseases.

 

“More than 50 human diseases have been linked to abnormal protein behaviour and disordered proteins, including Alzheimer’s disease, cystic fibrosis, type 2 diabetes, and certain cancers,” Associate Professor Hong said.

 

“It was clear that there was a need in disease research for the kind of test we have developed and we hope in the future it can help scientists uncover more about the role of disordered proteins in a wide range of diseases.”

 

Associate Professor Hong is a member of the La Trobe Institute for Molecular Science (LIMS), and La Trobe’s School of Agriculture, Biomedicine and Environment (SABE).

 

This study was conducted as a part of Associate Professor Hong’s Australian Research Council (ARC) Future Fellowship and National Health and Medical Research Council (NHMRC) Ideas grant and was initially funded by the Rebecca L. Cooper Medical Research Foundation Project Grant.

 

It was done in collaboration with scientists at the University of Melbourne, the Research Centre for Molecular Medicine (CeMM) of the Austrian Academy of Sciences and the Northwestern University in the United States.

 

Read the paper, “Global Analysis of Endogenous Protein Disorder in Cells” in Nature Methods here: https://www.nature.com/articles/s41592-024-02507-z  

We have a case study available upon request. Sean is a 38-year-old Victorian man who was diagnosed with early onset Parkinson's at the age of 36. He has no family history of Parkinson’s. He can speak about living with Parkinson's and the importance of research into the condition. He has climbed to Everest Base Camp to raise funds for Parkinson’s research and he is a past student of La Trobe University. 

 


Contact details:

Elaine Cooney
E.Cooney@latrobe.edu.au 
0487 448 734

More from this category

  • Government Federal, Medical Health Aged Care
  • 09/12/2024
  • 12:14
Catholic Health Australia

CHA backs AMA push for greater access to out-of-hospital care

Catholic Health Australia supports the Australian Medical Association’s call for greater access to out-of-hospital care for patients, outlined in its position paper released today. “We have been calling for reform to out-of-hospital care for the past year and are pleased to see the sector unite around this issue,” said Catholic Health Australia CEO Jason Kara. “Treatments like chemotherapy, dialysis, wound care, palliative care and post-surgical rehab can be conducted safely at home with better outcomes - but millions of patients are missing out. “We urgently need reforms that allow patients and their doctors to choose where they receive their care,…

  • Medical Health Aged Care
  • 09/12/2024
  • 10:55
Monash University

Monash Expert: Australia’s growing arthritis burden

The number of people living with arthritis in Australia is projected to increase by a third by 2040, suggests a modelling study, published in The Lancet Rheumatology. The model projects about 5.4 million Australians will have arthritis in 2040, 1.3 million (31 per cent) more than the estimated number of cases for 2025. Annual health system spending on osteoarthritis – the most common type of arthritis, and rheumatoid arthritis, the most common type of inflammatory arthritis – is forecast to exceed AUD $11.9 billion by 2040, if current spending levels continue, estimated at AUD $2,100 per person with osteoarthritis and…

  • Medical Health Aged Care
  • 09/12/2024
  • 07:30
Monash University

Small male weight gains increase risk of back pain and disability, local study finds

A comprehensive two-decades long study of 695 men living in Geelong found that gaining as little as three kilograms of weight over five years is linked to back pain and high rates of disability ten years later, highlighting the importance of maintaining a healthy weight. This is the first study to link body composition and back pain in a population-based sample of men. The study, led by Professor Anita Wluka, from the Monash University School of Public Health and Preventive Medicine, examined men with no or low-intensity back pain and disability between 2006–2010 within the Geelong Osteoporosis Study. Ten years…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.